Nurse Practitioner Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Kathalene Nottingham

Nurse Practitioner, Family Saint Albans, WV Nurse Practitioner

NPI 1447924469 CMS profile 10708087

987 Elliot St, Saint Albans, WV 25177

Open in the dashboard

General payments

$6,176

335 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kathalene Nottingham of Saint Albans, WV is reported in the CMS Open Payments database as having received $6,176 across 335 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,613 89
2024 General $2,225 125
2023 General $1,886 101
2022 General $452 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kathalene Nottingham
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Kathalene Nottingham were reported at $1,613. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Kathalene Nottingham Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $0 $124 $35–$379 $132
2022 $452 $141 $44–$430 $149
2023 $1,886 $154 $49–$476 $160
2024 $2,225 $165 $51–$504 $164
2025 $1,613 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Janssen Pharmaceuticals, Inc $1,018 48 payments
  2. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $985 77 payments
  3. Novartis Pharmaceuticals Corporation $804 52 payments
  4. AstraZeneca Pharmaceuticals LP $718 35 payments
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $580 30 payments
  6. Merck Sharp & Dohme Corporation $372 20 payments
  7. Pfizer Inc. $306 17 payments
  8. Novo Nordisk Inc $299 16 payments
  9. HeartFlow, Inc. $272 12 payments
  10. Bayer HealthCare Pharmaceuticals Inc. $253 7 payments
  11. Other $569 21 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $6,130 333 payments
  2. Education $46 2 payments
Products named General payments · program years 2022–2025
  1. XARELTO $1,018 48 payments
  2. LifeVest $985 77 payments
  3. LEQVIO $723 48 payments
  4. VERQUVO $411 22 payments
  5. JARDIANCE $384 23 payments
  6. WAINUA $299 14 payments
  7. FFRct $272 12 payments
  8. ELIQUIS $263 15 payments
  9. Kerendia $253 7 payments
  10. NURTEC ODT $247 13 payments
  11. Other $1,926 92 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

335 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record